Analysis of Effects of Myocardial Dilatation and Restrictive Changes on Cardiac Structure and Function in Patients with Hypertrophic Cardiomyopathy and Heart Failure
YE Ting-chun, CHEN Qiu
42nd Hospital of the People's Liberation Army, Leshan, 614100, Sichuan province, China
Abstract：【Objective】To investigate the effects of dilatation and restrictive changes of myocardiumon on cardiac structure and functional characteristics in patients with hypertrophic cardiomyopathy and heart failure.【Methods】A total of 82 patients with hypertrophic cardiomyopathy who were admitted to our hospital from February 2013 to February 2018 were enrolled in this study. All patients underwent thoracic echocardiography and magnetic resonance imaging. According to the results of ultrasound examination, the patients were divided into the dilated group (n=56) and the restricted group (n=26). The left atrial anteroposterior diameter (LAD), left ventricular ejection fraction (LVEF), maximum left ventricular wall thickness (LVWT), left ventricular end diastolic diameter (LVEDD), left atrial enlargement, ventricular wall hypertrophy and delayed ventricular wall enhancement were recorded and analyzed.【Results】The average age of the dilated group was younger than that of the restricted group, and the proportion of males was significantly higher than that of the restricted group. The difference was statistically significant (P<0.05).There was no significant difference in heart rate and plasma NT-proBNP levels between the two groups (P>0.05). Left atrial anteroposterior diameter, mitral regurgitation ratio, left atrial enlargement ratio and right ventricular enlargement ratio did not show any significant difference between the two groups (P>0.05). The proportions of LVEF, LVWT, tricuspid regurgitation, left and right atrial enlargement were significantly lower in the dilated group than in the restricted group. The ratios of LVEDD, LVWT<11mm and LVEF <50% in the dilated group were significantly greater than those in the restricted group; the differences were statistically significant (P<0.05). The maximum ventricular wall thickness, interventricular septum, partial left ventricular free wall hypertrophy ratio and ratio of delayed enhancement of ventricular septal or apical ventricular wall in the dilated group were lower than those in the restricted group. The proportions of simple interventricular septum hypertrophy, interventricular septum and left ventricular free wall delayed enhancement in the dilated were higher than those in the restricted group (P<0.05).【Conclusion】 Restrictive and dilated cardiomyopathy has a significant effect on cardiac structure and function in patients with hypertrophic cardiomyopathy complicated with heart failure. The degree of myocardial fibrosis and the hypertrophic site of the ventricular wall are important factors leading to changes in restrictive and dilated cardiomyopathy.
叶廷春, 陈秋. 肥厚型心肌病并心力衰竭患者心肌扩张性及限制性改变对心脏结构及功能的影响[J]. 医学临床研究, 2020, 37(2): 216-219.
YE Ting-chun, CHEN Qiu. Analysis of Effects of Myocardial Dilatation and Restrictive Changes on Cardiac Structure and Function in Patients with Hypertrophic Cardiomyopathy and Heart Failure. JOURNAL OF CLINICAL RESEARCH, 2020, 37(2): 216-219.
[1] 黄颖, 肖洁, 徐嘉,等. 扩张型心肌病慢性心力衰竭患者血浆脑利钠肽的变化及意义[J].安徽医科大学学报, 2016, 51(3):435-438.
[2] Kou H, Gao D, Ma R,et al. GW27-e0041 Relationship between hyperuricemia and renal damage and atherogenic index of plasma in the patients with primary hypertension[J].J Am Coll Cardiol,2016, 68(16):132.
[3] Kharabish AE. CMRI morphological and functional changes of the heart in myocarditis and dilated cardiomyopathy in acute pediatric heart failure[J].J Cardiovasc Magnetic Resonance,2016, 8(1):1-2.
[4] 赵华, 何继强, 姜蓓,等. 间隔心肌消融术与药物保守治疗对梗阻性肥厚型心肌病疗效的对比[J].中华心血管病杂志, 2016, 44(12):1015-1019.
[5] 李达波. 血清糖类抗原125及心肌肌钙蛋白Ⅰ水平与扩张型心肌病并慢性充血性心力衰竭患者心功能的相关性研究[J].实用心脑肺血管病杂志, 2017, 25(1):18-21.
[6] Legallois D, Belin A, Nesterov S V, et al. Cardiac rehabilitation improves coronary endothelial function in patients with heart failure due to dilated cardiomyopathy: A positron emission tomography study[J].Eur J Prevent Cardiol,2016, 33(19):129-136.
[7] 程赛楠, 崔辰, 李璐,等. 终末期肥厚型心肌病的MRI特征及预后分析[J].中国医学影像技术, 2017, 33(4):539-544.
[8] 乔锐, 乔峰, 杭天星,等. 大剂量曲美他嗪治疗老年扩张型心肌病心力衰竭临床观察[J].临床军医杂志, 2017, 45(6):646-647.
[9] 韩宝华, 吕珊珊, 罗晓婷,等. 扩张型心肌病慢性心力衰竭患者血浆脑利钠肽水平的临床意义[J].现代生物医学进展, 2017, 17(23):4576-4578.
[10] Akdis D, Medeiros-Domingo A, Gaertner-Rommel A, et al. Myocardial expression profiles of candidate molecules in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia compared to those with dilated cardiomyopathy and healthy controls[J].Heart Rhythm,2016, 13(3):731-741.
[11] Saito T, Asai K, Sato S, et al. Autophagic vacuoles in cardiomyocytes of dilated cardiomyopathy with initially decompensated heart failure predict improved prognosis[J].Autophagy,2016, 12(3):579-587.
[12] 张竹华, 翟军鹏, 戴梅,等. 消心痹方对肥厚型心肌病患者心脏功能及心率变异性的影响[J].世界中医药, 2017, 12(8):1844-1847.
[13] Yokokawa T, Sugano Y, Nakayama T, et al. Significance of myocardial tenascin-C expression in left ventricular remodelling and long-term outcome in patients with dilated cardiomyopathy[J].Eur J Heart Fail, 2016, 18(4):375-385.
[14] 赵先锋, 徐予, 朱中玉,等. 脐带间充质干细胞治疗慢性扩张型心肌病合并心力衰竭疗效观察[J].新乡医学院学报, 2017, 34(9):823-826.
2020, Vol. 37 
